SCHEMBL6528482

SCHEMBL6528482

COc1cccc(Cn2cnc(C)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPO P22079 3/20 0.52
CMA1 P23946 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
SIGMAR1 Q99720 1/20 0.49
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
GAA P10253 1/20 0.48
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47
TUBB2A Q13885 1/20 0.47
TUBB8 Q3ZCM7 1/20 0.47
TUBA3E Q6PEY2 1/20 0.47
TUBA1A Q71U36 1/20 0.47
TUBA1C Q9BQE3 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6528479 0.84 LPO (0.51) LPOCMA1MEN1KMT2ASIGMAR1
SCHEMBL6530144 0.81 CDK5 (0.51) CMA1MEN1KMT2AKDM4EALDH1A1
SCHEMBL22067900 0.79 QPCT (0.42) KDM4EALDH1A1TUBB4ATUBBTUBA3C
SCHEMBL25583831 0.79 CYP11B1 (0.55) MEN1KMT2AALDH1A1
SCHEMBL6528673 0.79 PHF8 (0.57) SIGMAR1KDM4EALDH1A1GAATP53
SCHEMBL4477317 0.79 CYP11B1 (0.55)
SCHEMBL1196872 0.77 HPGDS (0.51) KDM4EMAPT
Ethane SCHEMBL29134244 0.76 HPGDS (0.50) KDM4EMAPT
SCHEMBL27696269 0.76 LPO (0.68) LPOCMA1MEN1KMT2ASIGMAR1
SCHEMBL20331335 0.75 TP53 (0.41) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed